4//SEC Filing
CROSS HERB 4
Accession 0001209191-22-037111
CIK 0001532346other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:14 PM ET
Size
18.0 KB
Accession
0001209191-22-037111
Insider Transaction Report
Form 4
Atreca, Inc.BCEL
CROSS HERB
Chief Financial Officer
Transactions
- Disposition to Issuer
Employee stock option (right to buy)
2022-06-13−95,000→ 0 totalExercise: $13.97Exp: 2031-01-26→ Class A Common Stock (95,000 underlying) - Award
Employee stock option (right to buy)
2022-06-13+95,000→ 95,000 totalExercise: $1.84Exp: 2031-01-26→ Class A Common Stock (95,000 underlying) - Award
Employee stock option (right to buy)
2022-06-13+224,999→ 224,999 totalExercise: $1.84Exp: 2029-04-04→ Class A Common Stock (224,999 underlying) - Disposition to Issuer
Employee stock o16.74ption (right to buy)
2022-06-13−224,999→ 0 totalExercise: $12.06Exp: 2029-04-04→ Class A Common Stock (224,999 underlying) - Award
Employee stock option (right to buy)
2022-06-13+97,000→ 97,000 totalExercise: $1.84Exp: 2030-02-25→ Class A Common Stock (97,000 underlying) - Disposition to Issuer
Employee stock option (right to buy)
2022-06-13−97,000→ 0 totalExercise: $22.07Exp: 2030-02-25→ Class A Common Stock (97,000 underlying)
Footnotes (4)
- [F1]1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
- [F2]The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the "Option Repricing"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022. Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option. The Option Repricing does not apply to options held by non-employee directors of the Issuer.
- [F3]1/4 of the Option vests on 2/25/2020 and 1/48 of the Option vests in equal monthly installments as measured from 2/25/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
- [F4]2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
Documents
Issuer
Atreca, Inc.
CIK 0001532346
Entity typeother
Related Parties
1- filerCIK 0001230721
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 7:14 PM ET
- Size
- 18.0 KB